Straumann Holding AG (FRA:QS51) Days Sales Outstanding : 79.48 (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Straumann Holding AG Days Sales Outstanding?

Straumann Holding AG's average Accounts Receivable for the six months ended in Dec. 2023 was €552 Mil. Straumann Holding AG's Revenue for the six months ended in Dec. 2023 was €1,267 Mil. Hence, Straumann Holding AG's Days Sales Outstanding for the six months ended in Dec. 2023 was 79.48.

The historical rank and industry rank for Straumann Holding AG's Days Sales Outstanding or its related term are showing as below:

FRA:QS51' s Days Sales Outstanding Range Over the Past 10 Years
Min: 54.12 Med: 60.82 Max: 74.5
Current: 74.5

During the past 13 years, Straumann Holding AG's highest Days Sales Outstanding was 74.50. The lowest was 54.12. And the median was 60.82.

FRA:QS51's Days Sales Outstanding is ranked worse than
61.83% of 807 companies
in the Medical Devices & Instruments industry
Industry Median: 63.94 vs FRA:QS51: 74.50

Straumann Holding AG's Days Sales Outstanding increased from Dec. 2022 (71.31) to Dec. 2023 (79.48).

Straumann Holding AG Days Sales Outstanding Historical Data

The historical data trend for Straumann Holding AG's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Straumann Holding AG Days Sales Outstanding Chart

Straumann Holding AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

64.20

73.53

53.24

57.86

65.41

Straumann Holding AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															61.96	64.05	71.31	75.41	79.48

Competitive Comparison of Straumann Holding AG's Days Sales Outstanding

For the Medical Instruments & Supplies subindustry, Straumann Holding AG's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Straumann Holding AG's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Straumann Holding AG's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Straumann Holding AG's Days Sales Outstanding falls into.

Straumann Holding AG Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Straumann Holding AG's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (421.908	+	494.649)	/	2 )	/	2557.398	*	365
=	458.2785					/	2557.398	*	365
=	65.41

Straumann Holding AG's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (608.92	+	494.649)	/	2 )	/	1267.058	*	365 / 2
=	551.7845					/	1267.058	*	365 / 2
=	79.48

Straumann Holding AG (FRA:QS51) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Straumann Holding AG Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Straumann Holding AG's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Straumann Holding AG (FRA:QS51) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Straumann Holding AG (FRA:QS51) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

SAUHY:USA SAUHF:USA STMNz:UK 0QMV:UK STMN:Switzerland

Address

Peter Merian-Weg 12, Basel, CHE, 4002

Website

https://www.straumann-group.com

Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The company's core products are dental implants, and it holds roughly 30% of the global implant dentistry market, which is estimated to be worth roughly CHF 5.4 billion. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.

Straumann Holding AG (FRA:QS51) Headlines

No Headlines